High Note Wealth’s West Pharmaceutical WST Stock Holding History

High Note Wealth’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-15	Closed	-$3.94K	–	991
2025 Q3	$3.94K	Buy	+15	New	+$3.65K	﹤0.01%	571

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

High Note Wealth's WST Position: Q4 2025 in Review

High Note Wealth sold out of West Pharmaceutical (WST) in Q4 2025, closing a stake of 15 shares — an estimated $3.94K sold.

High Note Wealth first reported a position in WST in Q3 2025 and held it in 1 quarter. The position peaked at $3.94K in Q3 2025. 804 funds tracked by Wall St. Rank hold WST as of Q4 2025.

High Note Wealth reported no remaining West Pharmaceutical position as of Q4 2025 after selling out during the quarter.
High Note Wealth sold 15 West Pharmaceutical shares in Q4 2025, an estimated $3.94K.
High Note Wealth first reported a position in West Pharmaceutical in Q3 2025 and held it in 1 quarter.
High Note Wealth's West Pharmaceutical position peaked at $3.94K in Q3 2025.
804 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2025.

Based on High Note Wealth's 13F filing for Q4 2025, filed 5 Feb 2026.